VEGFA and neoplasm: As hypoxia has been shown to account for increased LD formation in tumor cells [16] and anti-VEGF-treated IGROV-1 tumors have increased hypoxic areas [6], we investigated whether hypoxia could drive LD formation in the tumor cells used in this study.